Find clinical trials for Ovarian Cancer in Warszawa, Mazowieckie
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near Warszawa, Mazowieckie, POL:
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Warsaw, Poland and 213 other locations
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Warsaw, Poland and 126 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Warsaw, Poland and 176 other locations
(ZN-c3) in subjects with Platinum-Resistant, High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Part 2 of the...
Phase 2
Warsaw, Masovian Voivodeship, Poland and 91 other locations
Ovarian cancer is a heterogeneous disease, characterized by complex molecular and genetic changes. The high expression of vascular ...
Phase 3
Warsaw, Poland and 181 other locations
activity in participants with advanced metastatic colorectal cancer, ovarian cancer, renal cancer or pancreatic c....
Phase 1
Warsaw, Masovian Voivodeship, Poland and 2 other locations
following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based...
Phase 3
Warsaw, Kondratowicza, Poland and 237 other locations
The primary objective is to compare pembrolizumab plus paclitaxel with or without bevacizumab to placebo plus paclitaxel with or without bevacizumab,...
Phase 3
Warsaw, Masovian Voivodeship, Poland and 187 other locations
tirumotecan with or without bevacizumab live longer without the cancer getting worse than those who receive standard of care treatment....
Phase 3
Warsaw, Masovian Voivodeship, Poland and 195 other locations
This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age...
Phase 1, Phase 2
Warsaw, Poland and 67 other locations
Clinical trials
Research sites
Resources
Legal